SARA / Free Tools / CVE / CVE-2022-30277

CVE-2022-30277 — BD Synapsys™, versions 4

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health informa

CVSS
5.7 MEDIUM
EPSS
0.04% (top 86.50%)
CWE
CWE-613
Published
2022-06-01T16:38:50.425Z
Last modified
2024-09-16T17:43:27.280Z
CVSS vector
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N

01What is this vulnerability?

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

02Affected products

VendorProductVersions
Becton Dickinson (BD)BD Synapsys™4.20

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

09References

Want this in your SOAR or SIEM?
SARA's API returns EPSS, CVSS, KEV, and an analyst-grade summary in one call.
Read the API reference →